ATE319707T1 - Verfahren zur herstellung von chinazolinen - Google Patents
Verfahren zur herstellung von chinazolinenInfo
- Publication number
- ATE319707T1 ATE319707T1 AT02730579T AT02730579T ATE319707T1 AT E319707 T1 ATE319707 T1 AT E319707T1 AT 02730579 T AT02730579 T AT 02730579T AT 02730579 T AT02730579 T AT 02730579T AT E319707 T1 ATE319707 T1 AT E319707T1
- Authority
- AT
- Austria
- Prior art keywords
- formula
- quinazolines
- producing
- compound
- solvate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/57—Nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0112061.7A GB0112061D0 (en) | 2001-05-18 | 2001-05-18 | Process for the production of quinazolines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE319707T1 true ATE319707T1 (de) | 2006-03-15 |
Family
ID=9914812
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02730579T ATE319707T1 (de) | 2001-05-18 | 2002-05-10 | Verfahren zur herstellung von chinazolinen |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1387839B1 (de) |
| JP (1) | JP2004537519A (de) |
| AT (1) | ATE319707T1 (de) |
| BR (1) | BR0209861A (de) |
| CA (1) | CA2447233A1 (de) |
| DE (1) | DE60209709T2 (de) |
| ES (1) | ES2255615T3 (de) |
| GB (1) | GB0112061D0 (de) |
| MX (1) | MXPA03010504A (de) |
| WO (1) | WO2002094815A1 (de) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE635308A (de) * | 1962-07-23 | |||
| GB1477607A (en) * | 1975-03-13 | 1977-06-22 | Roche Products Ltd | 2-amidino-4-hydroxy-1,2,3,4-tetrahydroisoquinoline and salts thereof |
| GB8719378D0 (en) * | 1987-08-15 | 1987-09-23 | Pfizer Ltd | Antiarrythmic agents |
| GB9700504D0 (en) * | 1997-01-11 | 1997-02-26 | Pfizer Ltd | Pharmaceutical compounds |
-
2001
- 2001-05-18 GB GBGB0112061.7A patent/GB0112061D0/en not_active Ceased
-
2002
- 2002-05-10 MX MXPA03010504A patent/MXPA03010504A/es active IP Right Grant
- 2002-05-10 JP JP2002591488A patent/JP2004537519A/ja not_active Withdrawn
- 2002-05-10 WO PCT/IB2002/001748 patent/WO2002094815A1/en active IP Right Grant
- 2002-05-10 ES ES02730579T patent/ES2255615T3/es not_active Expired - Lifetime
- 2002-05-10 DE DE60209709T patent/DE60209709T2/de not_active Expired - Fee Related
- 2002-05-10 EP EP02730579A patent/EP1387839B1/de not_active Expired - Lifetime
- 2002-05-10 AT AT02730579T patent/ATE319707T1/de not_active IP Right Cessation
- 2002-05-10 BR BR0209861-0A patent/BR0209861A/pt not_active IP Right Cessation
- 2002-05-10 CA CA002447233A patent/CA2447233A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2004537519A (ja) | 2004-12-16 |
| GB0112061D0 (en) | 2001-07-11 |
| CA2447233A1 (en) | 2002-11-28 |
| MXPA03010504A (es) | 2004-03-02 |
| EP1387839A1 (de) | 2004-02-11 |
| BR0209861A (pt) | 2004-06-15 |
| WO2002094815A1 (en) | 2002-11-28 |
| DE60209709D1 (de) | 2006-05-04 |
| EP1387839B1 (de) | 2006-03-08 |
| ES2255615T3 (es) | 2006-07-01 |
| DE60209709T2 (de) | 2006-10-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602004005323D1 (de) | Azidfreies verfahren zur herstellung von 1,2-diaminoverbindungen | |
| EP1432714A4 (de) | Chemische verbindungen | |
| CY1108041T1 (el) | Αναστολεις της rho-κινασης | |
| WO2004029045A3 (en) | Process for preparing quinazoline rho-kinase inhibitors and intermediates thereof | |
| WO2002076976A3 (en) | Rho-kinase inhibitors | |
| ATE529409T1 (de) | Verfahren zur herstellung von kristallinen aripiprazolformen | |
| DE50106029D1 (de) | Verfahren zur Herstellung von Polycarbonat | |
| DE60111121D1 (de) | Klarlacke, sowie Verfahren zur Herstellung von Mehrschichtüberzügen | |
| WO2004043379A3 (en) | Chemical compounds | |
| DE60239842D1 (de) | Verfahren zur Herstellung von 10,11-dihydro-10-oxo-5h-dibenzoÄb,fÜazepin-5-carboxamid | |
| DE602004005881D1 (de) | Substituierte pyrazinonverbindungen zur behandlung von entzündungen | |
| DE60204464D1 (de) | Verfahren zur herstellung von ethern, vorzugsweise von thf | |
| DE60214629D1 (de) | Verfahren zur Zersetzung von Michael-Addukten | |
| DE69824839D1 (de) | Verfahren zur herstellung von 2-aryl-3-aryl-5-halogen-pyridinen, verwendbar als cox-2 inhibitoren | |
| DE60210778D1 (de) | Verfahren zur herstellung von 4-amino-2,5-bisheterocyclylchinazolinen | |
| DE602004014264D1 (de) | Verfahren zur herstellung von olanzapin | |
| DE60105314D1 (de) | Verfahren zur herstellung von taxanderivaten | |
| DE60201212D1 (de) | Verfahren zur Herstellung von Stickstofftrifluorid | |
| ATE385232T1 (de) | Verfahren zur herstellung von 3, 3', 6, 6'- tetraalkylen-2, 2'-biphenolen und 3, 3', 6, 6'- tetraalkylen-5, 5'-dihalo-2, 2' biphenolen | |
| ATE319707T1 (de) | Verfahren zur herstellung von chinazolinen | |
| CY1107287T1 (el) | Χρηση της ερυθροποιητινης, καθως και παραγωγων αυτης για τη θεραπεια σχιζοφρενειων και συναφων ψυχωσεων | |
| DE50201944D1 (de) | Verfahren zur Chlorierung von Methylsilanen | |
| ATE496038T1 (de) | Verfahren zur herstellung von quetiapin | |
| ATE267820T1 (de) | Prozess zur herstellung von paclitaxel | |
| EP1436279A4 (de) | Chemische verbindungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |